= Emerging. More than 5 years before clinical availability. (16.60%, 2024)
= Expected to be clinically available in 1 to 4 years. (37.02%, 2024)
= Clinically available now. (46.38%, 2024)
No entry found.
Financial Disclosure
Description
Y/N
Source
Grants
yes
Waters, AstraZeneca
Salary
no
Board Member
no
Stock
no
Expenses
no
IP Royalty
yes
DESI patent
Planning to mention or discuss specific products or technology of the company(ies) listed above:
no